Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 1, keine Gesamtzahl für „prucalopride“
Suchtreffer
Begriffe & Kennungen
Resolor · 4.5 · Although prucalopride may be a weak substrate for P-glycoprotein (P-gp), it is not an inhibitor of P-gp at cli
Eintrag öffnenResolor · 4.5 · Although prucalopride may be a weak substrate for P-glycoprotein (P-gp), it is not an inhibitor of P-gp at cli
Eintrag öffnenResolor · 4.5 · Effects of other medicinal products on pharmacokinetics of prucalopride Ketoconazole (200 mg twice daily), a p
Eintrag öffnenResolor · 4.5 · Effects of other medicinal products on pharmacokinetics of prucalopride Ketoconazole (200 mg twice daily), a p
Eintrag öffnenResolor · 4.5 · Effects of prucalopride on pharmacokinetics of other medicinal products A 30% increase in plasma concentration
Eintrag öffnenResolor · 4.5 · Effects of prucalopride on pharmacokinetics of other medicinal products A 30% increase in plasma concentration
Eintrag öffnenResolor · 4.5 · Prucalopride did not inhibit specific CYP450 activities in in vitro studies in human liver microsomes at thera
Eintrag öffnenResolor · 4.5 · Prucalopride did not inhibit specific CYP450 activities in in vitro studies in human liver microsomes at thera
Eintrag öffnenResolor · 4.5 · Prucalopride had no clinically relevant effects on the pharmacokinetics of warfarin, digoxin, alcohol, paroxet
Eintrag öffnenResolor · 4.5 · Prucalopride had no clinically relevant effects on the pharmacokinetics of warfarin, digoxin, alcohol, paroxet
Eintrag öffnenResolor · 4.5 · Prucalopride has a low pharmacokinetic interaction potential. It is extensively excreted unchanged in urine (a
Eintrag öffnenResolor · 4.5 · Prucalopride has a low pharmacokinetic interaction potential. It is extensively excreted unchanged in urine (a
Eintrag öffnenResolor · 4.8 · Palpitations were reported in 0.7% of the placebo patients, 0.9% of the 1 mg prucalopride patients, 0.9% of th
Eintrag öffnenResolor · 4.8 · Palpitations were reported in 0.7% of the placebo patients, 0.9% of the 1 mg prucalopride patients, 0.9% of th
Eintrag öffnenprucalopride
Eintrag öffnenprucalopride succinate
Eintrag öffnenprucalopride succinate
Eintrag öffnen